Label: ASPERCREME LIDOCAINE XL- lidocaine patch

  • NDC Code(s): 62168-0585-2
  • Packager: Lead Chemical Co., Ltd.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated May 29, 2026

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    Lidocaine 4%

  • Purpose

    Topical anesthetic

  • Use

    for the temporary relief of pain

  • Warnings

    For external use only

    Do not use

    •
    on wounds or on irritated or damaged skin
    •
    more than 1 patch on your body at a time or with other topical analgesics at the same time
    •
    with a heating pad

    When using this product

    •
    use only as directed
    •
    do not bandage tightly
    •
    avoid contact with eyes and mucous membranes
    •
    do not expose the area to local heat or to direct sunlight

    Stop use and ask a doctor if

    •
    condition worsens or symptoms persist for more than 7 days
    •
    symptoms clear up and occur again within a few days
    •
    redness is present or excessive skin irritation occurs
    •
    you experience severe burning pain, swelling, or blistering where the product was applied

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children and pets.

    Used patches may still contain the drug product that can produce serious adverse effects if ingested by children or pets. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    •   adults and children 12 years of age and older:

    •
    clean and dry affected area
    •
    remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
    •
    carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
    •
    once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
    •
    apply to the affected area not more than 3 to 4 times daily
    •
    wash hands after applying or removing patch. Throw away the patch after folding sticky ends together.

    •   children under 12 years of age: ask a doctor

  • Inactive ingredients

    aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

  • Package/Label Principal Display Panel

    LIDOCAINE
    #1
    BRAND*
     
    MAX STRENGTH†
    Aspercreme®
    WITH 4% LIDOCAINE
    PAIN RELIEVING PATCH
     
    ODOR FREE
    XL PATCH
    71% LARGER**
    NUMBS AWAY PAIN
     
    Fast Acting
    Targets Nerves
    Flexible Fabri    c
     
    Contains 1 Patch
    4-3/4” X 7-7/8” (12 cm x 20 cm)
     
    Pain Relieving Ointment on a
    Breathable Adhesive Pad

    *Among OTC topical analgesics
    †Among OTC topical analgesics for the
    indicated Use(s)
    **Than 10 cm X 14 cm Aspercreme® patches.

     
    Distributed by: Chattem, Inc.,
    P.O. Box 2219, Chattanooga, TN 37409-0219
    ©2025     www.aspercreme.com
    Made in Japan

    image-01

    Label

  • INGREDIENTS AND APPEARANCE
    ASPERCREME  LIDOCAINE XL
    lidocaine patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62168-0585
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE411.4 mg
    Inactive Ingredients
    Ingredient NameStrength
    DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    NONOXYNOL-30 (UNII: JJX07DG188)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    TARTARIC ACID (UNII: W4888I119H)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    UREA (UNII: 8W8T17847W)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62168-0585-2240 in 1 CARTON05/28/2021
    11 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)10/15/2017
    Labeler - Lead Chemical Co., Ltd. (693727091)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!